Physician profile
Donna Bowers
NPI 1750439394
$16,498.62
in general payments reported to CMS, 2019-2025
31 companies · $3,761 in 2025
The $3,761 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,472 · 2022: $3,450 · 2023: $3,453 · 2024: $3,362 · 2025: $3,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $115 · Education: $97.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,364.01 |
| Consulting Fee | $115.00 |
| Education | $97.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,563.18 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Abbvie INC. | $2,454.52 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,905.63 | 2021-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $1,190.19 | 2021-2025 | Invega Sustenna, Spravato |
| Lundbeck LLC | $1,160.24 | 2021-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $960.69 | 2021-2025 | Rexulti, Abilify Maintena, Nuedexta |
| Neurocrine Biosciences, INC. | $848.95 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $833.44 | 2021-2025 | Lybalvi, Aristada |
| Takeda Pharmaceuticals U.S.A., INC. | $817.15 | 2021-2025 | Trintellix |
| Progenics Pharmaceuticals, INC. | $633.50 | 2022 | |
| Almatica Pharma LLC | $570.33 | 2021-2025 | Loreev Xr, Sertraline Hcl |
| Vanda Pharmaceuticals INC. | $433.93 | 2021-2025 | Fanapt |
| Axsome Therapeutics, INC. | $310.28 | 2023-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $271.67 | 2024-2025 | Qelbree |
| Sunovion Pharmaceuticals INC. | $225.92 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $208.19 | 2022-2025 | Quviviq, Quviviq |
| Avanir Pharmaceuticals, INC. | $170.54 | 2021-2022 | |
| Janssen Biotech, INC. | $144.14 | 2022-2023 | Erleada |
| Novartis Pharmaceuticals Corporation | $120.68 | 2025 | |
| Janssen Scientific Affairs, LLC | $115.00 | 2025 | Spravato |
| Astellas Pharma US INC | $114.31 | 2024-2025 | Xtandi |
| Eisai INC. | $108.84 | 2021-2022 | |
| Indivior INC. | $65.01 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $62.29 | 2021-2022 | |
| Sage Therapeutics, LLC | $55.10 | 2021 | |
| Hollister Incorporated | $32.34 | 2021 | |
| Corium, LLC | $31.68 | 2022 | |
| Tonix Medicines, INC. | $31.64 | 2025 | Tonmya |
| Noven Therapeutics, LLC | $30.30 | 2023 | Xelstrym, Secuado |
| E.R. Squibb & Sons, L.L.C. | $15.81 | 2025 | Cobenfy |
| Sumitomo Pharma America, INC. | $13.13 | 2023 | Latuda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.